USA David H. Crean, PhD, Managing Director for Objective Capital Partners, a leading investment banking advisory firm examines the healthcare market for 2018. Following a decade high of VC invested in 2017, and on a record pace again in 2018, valuations continue to move higher across all stages within…
Innovation Buck Dossey, an expert in digital marketing and audience manager at Adobe, discusses consumer needs in healthcare and the importance of adopting a digital health strategy. Joining the digital transformation race today means that many companies will have to transform to become digitally agile. While the topic of digital transformation permeates…
Regulation Chester “Chip” Davis, Jr, the President and CEO of the Association for Accessible Medicines (AAM) in the United States, discusses the contradictory nature of Trump’s efforts to lower drug prices. The President has forcefully pledged to provide relief to these patients and their families, but his own trade policy threatens…
USA After her son was diagnosed with SYNGAP1 – an extremely rare gene mutation – Monica founded Bridge the Gap – SYNGAP Education and Research Foundation to support families of those suffering from the illness and to accelerate the path to better therapies. Here she discusses the importance of community for tackling rare…
Innovation Meghann Chilcott, Senior Vice President of OrderInsite, discusses the changing role of pharmacists and technicians. Patients are consumers, and they expect more from pharmacies than a collection of pill bottles. Local pharmacists have seen their roles continually change over recent years due to enhanced technology that allows them better…
Innovation Article contributed by Carla Smith, Executive Vice President of The Healthcare Information and Management Systems Society (HIMSS) for PharmaBoardroom. We must assertively bend the arc of technology towards our patients, clinicians, researchers, and caregivers, and re-humanise the health system. One of the many ways patients are de-humanized in a health…
Opioids Today the USA finds itself in the midst of an opioid crisis, claiming 40,000 American lives every year – a comparable death toll to the HIV epidemic at its peak. Aside from the devastating human cost, it imposes a staggering annual economic burden of $504 billion US dollars, around three…
Algeria Ismael Chikhoune of the US-Algeria Business Council (US-ABC) expounds upon the evolving levels of business cooperation between the USA and Algeria, opportunities for US healthcare companies in Algeria, and the structural changes needed to cement Algeria as a top investment destination. Could you inform our readers on your background…
USA Theranos the US biotech start-up is to be dissolved after bad-blood tests exposed. Theranos was set up in Silicon Valley in 2004 by 19-year-old founder Elizabeth Holmes who was considered as a young trailblazer in the biotech industry. She was a student at Stanford University when she imagined the idea for…
Russia In the latest twist in the ongoing story of Russian interference in the US presidential elections of 2016, it has emerged that Russian internet trolls and automated bots spread misinformation about vaccines on Twitter to stir up division in the US. Researchers at George Washington University, while working on a…
USA Blue-chip drug makers holding USD 200 billion in cash, mostly overseas, will start investing more of it in mergers and acquisitions (M&A) after President Trump’s tax overhaul slashed the cost of spending the money in the US, debt-ratings firm Moody’s predicts. The ratings firm names Amgen, Pfizer, Gilead, and Celgene…
USA Tech giant Amazon’s acquisition of online pharmacy PillPack has caused the stock prices of rival healthcare distributors in the US to fall dramatically. With this move, Amazon has signalled its intent to move into the medical distribution arena and promises to seriously disrupt the way the industry operates. “This acquisition…
See our Cookie Privacy Policy Here